Zydus seeks DCGI approval for monoclonal antibodies cocktail
Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants
Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
This marks Glenmark's first synthetic decapeptide injectable approval
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Subscribe To Our Newsletter & Stay Updated